BRIDGEBIO PHARMA

Lobbying Spend

—

Filings

Firms Hired

Active Period

2025–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	7	2

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
MARSHALL & POPP, LLC	—	7
TODD STRATEGY GROUP	—	3

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	8
SENATE	8
Centers For Medicare and Medicaid Services (CMS)	6
Food & Drug Administration (FDA)	6
Health & Human Services, Dept of (HHS)	2

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	9
Health Issues	Health Issues	1
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	1
Medicare/Medicaid	Medicare/Medicaid	1
Budget/Appropriations	Budget/Appropriations	1

BRIDGEBIO PHARMA — Lobbying Disclosure | Poliscope